Search

Calmare NJ USA

Tag

CIPN therapy

Great article on Calmare by American News Report

March 21, 2012

So pleased to see the U.S. healthcare media recognizing the importance of Calmare Therapy (and taking the time to document the very positive clinical trial results at Massey Cancer Institute, U. of Wisconsin and Mayo Clinic!) This article, “Innovative Pain Device Relieves Chronic Pain Without Drugs”  is accurate and informative.  Looking for facts and documentation? Please see below (live links included):

Innovative Pain Device Relieves Chronic Pain Without Drugs

One of the greatest frustrations of patients and healthcare providers alike is dealing with pain, particularly chronic pain. And nowhere is this more apparent than for cancer patients who endured months or years of chemotherapy, and are left with peripheral neuropathy, a chronic pain condition.

Patients who have agonized through chronic pain say an emerging new treatment has improved their lives – without the use of painkilling drugs. “It’s just a miracle,” Michelle Jacobson, a breast cancer survivor, told a Rhode Island television station.

This non-invasive chronic pain solution is called the Calmare Pain Therapy Treatment. Calmare uses a biophysical “scrambler” device which transmits low doses of electricity through electrodes on the skin in order to block pain. In essence, the Calmare scrambler “tricks” the brain into thinking there isn’t pain.

Researcher, bioengineer, professor, and founder of the Delta Research & Development center in Rome, Giuseppe Marineo developed the Calmare scrambler. The device was named after the Italian word “calmare”, which means “to ease” or “to soothe”.

The Calmare scrambler is most often used for chemotherapy-induced peripheral neuropathy, which causes sensations of burning, numbness, aching, coldness, itching, and tingling. However, Calmare is also being used to treat other chronic pain conditions, including lower back pain, neck pain, diabetic pain, fibromyalgia, post-surgical pain, RSD (Reflex Sympathetic Dystrophy), and radiating pain.

The Calmare device was approved by the Food and Drug Administration in 2009, but is only available at 16 private pain clinics in the United States, mostly on the east coast. Wounded soldiers and veterans are also receiving Calmare Pain Therapy at the Walter Reed Army Medical Center and nearly a dozen other U.S. military facilities. The Department of Defense is seeking alternative forms of pain management to discourage the overuse of painkillers, which are widely used by injured veterans returning from Iraq and Afghanistan.

Medical professionals and clinical studies are reporting promising results from Calmare’s drug-free device.

In a clinical study at the University of Wisconsin, researchers found that Calmare scrambler therapy showed measurable results in helping patients with Chemotherapy Induced Pain Neuropathy. “This technology has consistently shown very impressive results in our blind study,” reports Toby Campbell, MD, chief of Palliative Medicine, University of Wisconsin. 

In a pilot trial of the Calmare device, Massey Cancer Center in Richmond, Virginia found a dramatic reduction in CIPN pain with no toxicity side effect. The 2010 study was published in the Journal of Pain and Symptom Management.

The Mayo Clinic is also requesting volunteers in a clinical trial using Calmare scrambler technology to analyze pain associated with post-herpetic neuralgia.

CIPN patient shares her experience with Calmare Therapy

February 15, 2012 – Amsterdam

(reprinted with patient permission)

A Letter from Nelia B (Condition: CIPN after Chemo Taxol Therapy)

For the past 2 1/2 years, I’ve been suffering from severe CIPN in my feet, after undergoing Taxol therapy for breast cancer. Three months after finishing the chemo, the neuropathy got much worse. Since then I’ve been on a high dose of pain medication (Gabapentin, Venlafaxine, Tramadol). Still my pain kept being at a level between 5 to 10. I also tried morphine patches, two painful and unsuccessful nerve blocks, cortisone injections, acupuncture, tens treatments and vitamin B12 shots. Nothing helped.

My doctors told me that my CIPN was chronic and not much else could be done about it. Meanwhile, I kept researching options and read about the clinical trials for CIPN with “Calmare Therapy” at the Massey Cancer Center, as well as at the University of Wisconsin (UW) Carbone Center. The doctors at both institutions told me that they experienced positive outcomes. I was also able to talk to a patient who underwent Calmare treatment, which was encouraging also. Then in the fall of 2011, I learned that the US Military opened several Calmare centers.

In December 2011, I decided to give it a try and contacted Dr. Cooney at the Rutherford Allied Medical Group in the United States. Afraid of being disappointed, I was a skeptical patient. But after the first treatment, my feet felt relaxed and I could sense a slight relief. Thereafter, I got better with every treatment and started cutting down the pain medication. After 10 treatments I was on 10% pain medication and the pain was at level 3 to 5. When I returned home the pain slightly increased, but then it stabilized. Although I am not pain free, I feel so much better.

The Calmare treatment has given me back some quality of live, I did not have in three years. I’ve much more energy, my head is clear–being on much less medication–and I feel hopeful! It’s great to be on the street and look down the block, knowing that I can actually walk there; it is even better that I can finally take my children to the playground. My family is very relieved seeing me feeling better.

I’m very grateful to have found the Rutherford Allied Medical Group in New Jersey. Thank you Dr. Cooney and Dr. Michel for the wonderful care!

If you suffer from CIPN, you absolutely should give it a try. Good luck!

Nelia B.

Mayo Clinical Trial using Calmare scrambler therapy for study

February 2, 2012

The Mayo Clinic is still posting for study participants to engage in scrambler therapy treatment for chronic pain in patients with rash from Varicella Zoster Virus infection. To learn more, visit http://clinicaltrials.mayo.edu/clinicaltrialdetails.cfm?trial_id=101568

Chemotherapy-induced peripheral neuropathy (CIPN) patient begins Calmare Therapy

As we mentioned a few weeks ago, we welcomed our first Calmare Therapy patient from Europe (Amsterdam) this week who is undergoing treatment to combat chronic bilateral foot pain as a result of chemotherapy-induced peripheral neuropathy, or CIPN. As we and others have shared in the past, CIPN pain is notoriously difficult to treat successfully.

Our patient contracted CIPN three months after undergoing chemotherapy for breast cancer more than three years ago.  Her pain level escalated to a seven and she began having difficulty walking. She is undergoing 10 Calmare treatments and her outcome looks very positive. We look forward to sharing her outcome as she therapy progresses.

Dr. Michael Cooney

A CIPN patient from Amsterdam comes to NJ for Calmare Therapy

The recent findings by the University of Wisconsin that Calmare Therapy is one of the first therapies discovered to successfully treat chemotherapy-induced peripheral neuropathy (CIPN) during and after chemotherapy treatment  is making a big impact on the cancer therapy community. In the next few weeks, we will welcome patients from as far away as The Netherlands who are coming to NJ to seek treatment for this debilitating pain. We hope that one of these patients will share their experience on video that we can share with you all. Until then, wishing you a peaceful, happy and pain-free weekend.

Talk with Dr. Cooney Live on Friday, Nov. 4

Dr. Cooney shares a laugh with one of his patients after her Calmare Therapy treatment.
Dr. Michael J. Cooney of Rutherford Allied Medical Group will be discussing Calmare Pain Therapy Treatment on Friday, Nov. 4 from 3-4 p.m. (Eastern time) on Joseph Aquilino’s popular and informative program, “RSD and You”. 
 
Joey is a nationally-recognized advocate of RSD treatment and research. He also lives with the disease himself. 
 
Listeners are invited to call in at (310) 982 – 4253  and ask Dr. Cooney questions about this non-invasive, drug-free, pain-free treatment for chronic pain–RSD, fibromyalgia and other types of neuropathy. Log in at  http://www.blogtalkradio.com/joeygiggles

Is Calmare Therapy right for your chronic pain condition?

In order for patients to achieve the most positive outcomes from any therapy, treatment or medication, the solution must be appropriate for the specific condition being treated. Calmare Therapy is beneficial for patients living with treatment-resistant neuropathic chronic pain for a year or more as a result of these types of conditions:

  • Chronic pain syndrome
  • Cancer-related neuropathy
  • Chemotherapy-induced peripheral neuropathy (CIPN)
  • Reflex sympathetic dystrophy (RSD)
  • Fibromyalgia
  • Pain neuropathy
  • Radiating pain
  • Diabetic pain
  • Lower back pain
  • Chronic neck pain
  • Failed back surgery syndrome
  • Phantom limb syndrome
  • Sciatica

Calmare Pain Therapy Treatment® technology is FDA-cleared, non-invasive and pain-free. Unlike debilitating painkilling drugs, this therapy has no side effects. To learn more, tour our site and call (201) 933 – 4440 to learn more.

New U. of Wisconsin study supports Calmare for CIPN treatment

More and more cancer patients are surviving the disease but suffer with debilitating pain as a result of chemotherapy treatment, particularly in the feet and hands. The nerve damage can affect the patient’s ability to walk and use their hands. But an NBC News affiliate broadcast this new report on October 11 about a new  clinical study by the University of Wisconsin which determined Calmare’s MC-5A scrambler therapy is the first known therapy to show measurable results in helping to alleviate CIPN pain. “This technology has consistently shown very impressive results in our blind study, ” reports Toby Campbell, MD, chief of Palliative Medicine, University of Wisconsin.

As a result, a larger more extensive study has been approved. For anyone interested in participating in the study at the University of Wisconsin-Madison, call 800-622-8922.

Dr. Michael J. Cooney

Rutherford Allied Medical Group

Chemo-induced peripheral neuropathy (CIPN) and Calmare Therapy

I’ve been asked on radio programs more than once about CIPN and how Calmare can help. There is no negating that chemo saves lives every day. But the treatment often takes a toll on the rest of the body. As a result, the patient can be dealing with a newly developed case of chronic pain. One of the root causes of this pain is a result of the toxicity of the heavy metals, Taxanes and Cisplatinin, particularly.

Calmare Pain Therapy Treatment has proven to be particularly effective in combating this chronic pain. My team and I spent years researching, interviewing and visiting manufacturers who produce technology to alleviate chronic pain. One of the decisive factors was a scientific report published last year by Thomas J. Smith, MD, Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit at Virginia Commonwealth University’s Massey Cancer Center.

The study, one of the first detailed studies conducted in the United States since FDA clearance, concluded, “Patient-specific cutaneous electrostimulation with the MC5-A Calmare device appears to dramatically reduce pain in refractory CIPN patients with no toxicity.” CIPN, a debilitating side effect for 30 – 40 percent of cancer patients, causes sharp ongoing pain in the hands and feet and affects an estimated four million cancer patients in the United States alone.

 Their specific findings:

  •  Calmare Pain Therapy Treatment relieved refractory (resistant) CIPN pain quickly and significantly, with virtually no side effects.
  • Patients experienced a 64% reduction in pain, on average.
  • Four of 16 patients had a complete disappearance of pain.
  • Some patients had return of complete or partial normal sensation and relief of numbness, as well as relief of pain.
  • Some pain relief is durable for months but may require re-treatment and maintenance.

For those of us with expertise in pain management, these data findings are both astounding and inspiring. If you or a loved one undergoing chemotherapy treatment would like more information, please feel free to contact me personally.

Dr. Cooney

Blog at WordPress.com.

Up ↑

%d bloggers like this: